NCT06514196View on ClinicalTrials.gov

Post- Approval Hintermann Series H® Study 1

Active, not recruitingOBSERVATIONAL
Enrollment

298

Participants

Timeline

Start Date

June 18, 2020

Primary Completion Date

November 30, 2024

Study Completion Date

January 20, 2025

Conditions
Ankle OsteoarthritisPost-Traumatic Osteoarthritis of AnkleOsteoarthritis of Ankle Secondary to Inflammatory Arthritis (Disorder)
Interventions
DEVICE

Hintermann Series H3 Total Ankle Replacement System

The H3 includes a metal tibial component, a polyethylene sliding insert (PE inlay), and a metal talar component.

Trial Locations (1)

CH-4101

Kantonsspital Baselland, Bruderholz

Sponsors

Lead Sponsor

DT MedTech, LLC
All Listed Sponsors
lead

DT MedTech, LLC

INDUSTRY